We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...

There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...

We tried Shark's vast vacuum lineup and explored the effectiveness of features like lift-away pods, dirt detection, and ...

The ASX was trading amid volatility this morning, swinging between modest gains and losses as Wall Street’s nerves set off a ...

Skyfall’s flooded timber, swampy oak thickets, 20-acre lake and adjacency to the Trinity River is as attractive to ducks as ...

I'm Dan Maller, Head of Investor Relations at BeiGene ... which is akin to that of Gilead and HIV and Vertex in cystic fibrosis. Our focus for 2025 is to deliver upon three strategic pillars ...

None of Vertex’s other brands have a Richmond-area presence. Long told BizSense that Ugly Dumpling ... “I can’t tell you the number of people that have popped their head in wanting to see what it ...

Officials at a San Antonio-area charter school said Thursday evening they had confirmed ... The statement was provided by the charter school's management company, Vertex Education. However, a letter ...

In both experiments, to prevent eye and head movement artifacts ... This step was performed to compare accuracies among different area/activity priors. The process was repeated 10 times per pair of ...

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.